This paper evaluates the reasons behind the rise in the use of proton beam for prostate cancer, the economics drivers behind it, and the evidence that exists to support it.
It concludes that clinical outcome data underlying the notion that this is a superior treatment remains sparse and discusses what is needed to fill in the gaps.
Written by:
Zietman A. Are you the author?
Department of Radiation Oncology, Massachusetts General Hospital, Fruit Street, Boston, MA 02114, USA.
Reference: Rep Pract Oncol Radiother. 2013 Jul 3;18(6):338-342.
PubMed Abstract
PMID: 24416575
UroToday.com Prostate Cancer Section
